The Molecular Clock Mediates Leptin-Regulated Bone Formation  by Fu, Loning et al.
Cell, Vol. 122, 803–815, September 9, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.cell.2005.06.028
The Molecular Clock Mediates
Leptin-Regulated Bone FormationLoning Fu,1,2,6 Millan S. Patel,1,2,6 Allan Bradley,4
Erwin F. Wagner,5 and Gerard Karsenty1,2,3,*
1Department of Molecular and Human Genetics
2Bone Disease Program of Texas
3Children’s Nutrition Research Center
Baylor College of Medicine
Houston, Texas 77030
4Wellcome Trust Sanger Institute
Wellcome Genome Campus
Hinxton
Cambridge CB10 1SA
United Kingdom
5Research Institute of Molecular Pathology
A-1030 Vienna
Austria
Summary
The hormone leptin is a regulator of bone remodeling,
a homeostatic function maintaining bone mass con-
stant. Mice lacking molecular-clock components (Per
and Cry), or lacking Per genes in osteoblasts, display
high bone mass, suggesting that bone remodeling
may also be subject to circadian regulation. More-
over, Per-deficient mice experience a paradoxical in-
crease in bone mass following leptin intracerebro-
ventricular infusion. Thus, clock genes may mediate
the leptin-dependent sympathetic regulation of bone
formation. We show that expression of clock genes in
osteoblasts is regulated by the sympathetic nervous
system and leptin. Clock genes mediate the antiprolif-
erative function of sympathetic signaling by inhibiting
G1 cyclin expression. Partially antagonizing this in-
hibitory loop, leptin also upregulates AP-1 gene ex-
pression, which promotes cyclin D1 expression, osteo-
blast proliferation, and bone formation. Thus, leptin
determines the extent of bone formation by modulat-
ing, via sympathetic signaling, osteoblast prolifera-
tion through two antagonistic pathways, one of which
involves the molecular clock.
Introduction
Bone remodeling, the physiological process whereby
bone mass is maintained constant during adulthood, is
comprised of two phases. There is first a rapid phase
of resorption of preexisting mineralized bone by osteo-
clasts, the bone-resorbing cells, followed by a relatively
slow phase of de novo bone formation by osteoblasts,
the bone-forming cells (Rodan and Martin, 2000). Os-
teoblasts have another function during bone remodel-
ing: they control osteoclast differentiation. Bone re-
modeling, which is only partially understood at the
molecular level, is disrupted in several frequent skeletal
degenerative diseases. That one of these diseases, os-*Correspondence: karsenty@bcm.tmc.edu
6 These authors contributed equally to this work.teoporosis, is the most prevalent degenerative disease
in developed countries (Riggs and Melton, 1986) ex-
plains the extent of the research effort underway to
elucidate the molecular bases of this physiological
function.
As expected for such a dynamic and complex pro-
cess, bone remodeling is tightly controlled through two
types of regulation (Chien and Karsenty, 2005). The first
is exerted locally by factors secreted by either osteo-
blasts or osteoclasts. These include, but are not limited
to, RANK ligand and osteoprotegerin, which control os-
teoclast differentiation, and insulin-like growth factors and
other mitogens that affect bone formation. The second
level of regulation is exerted systemically by hormones,
such as sex steroids, parathyroid hormone, and leptin,
and by neural inputs. This systemic regulation often im-
pinges upon the expression of local regulators of bone
mass. Among the many systemic regulators, leptin is
nearly unique, as it affects profoundly both arms of
bone remodeling. After binding to its receptor on hypo-
thalamic neurons, leptin regulates, by targeting only
one cell type, the osteoblast, bone formation (via the
sympathetic nervous system [SNS]), and osteoclast dif-
ferentiation (via the SNS and cocaine- and amphet-
amine-regulated transcript, or CART) (Ducy et al., 2000;
Takeda et al., 2002; Elefteriou et al., 2005). A remarkable
aspect of leptin’s regulation of bone mass is that its
mediators do not mediate leptin’s other functions in an-
imals that are unchallenged, i.e., fed with a normal diet.
Indeed, mice unable to produce norepinephrine or me-
diate sympathetic signaling through the β2-adrenergic
receptor (Adrβ2) have a high-bone-mass phenotype but
are lean and fertile (Takeda et al., 2002; Elefteriou et al.,
2005). Likewise, mice lacking CART are osteoporotic
but are lean on a normal diet and fertile (Elefteriou et
al., 2005). Conceivably, other molecules involved in the
leptin-dependent sympathetic regulation of bone mass
may not affect either body weight or reproduction.
To maintain bone mass constant, bone resorption
and bone formation occur sequentially and in a bal-
anced manner. Thus, bone remodeling is a homeostatic
function (Rodan and Martin, 2000; Boyle et al., 2003).
Since most homeostatic functions occur in a circadian
manner (Lowrey and Takahashi, 2004; Perreau-Lenz et
al., 2004), this feature suggests that the circadian clock
could control bone mass. The diurnal variation in the
synthesis of type I collagen and osteocalcin, the two
main biosynthetic products of osteoblasts, supports
this hypothesis (Simmons and Nichols, 1966; Gundberg
et al., 1985).
Most physiological processes in mammals display
circadian rhythms that are driven by the endogenous
circadian clock. This clock comprises a central compo-
nent located in the hypothalamic suprachiasmatic nu-
cleus and subordinate clocks in peripheral tissues.
Both central and peripheral clocks are operated by
positive- and negative-feedback loops of circadian
genes (Reppert and Weaver, 2002; Schibler and Sas-
sone-Corsi, 2002; Fu and Lee, 2003). The positive-feed-
back loop is driven by the basic helix-loop-helix-PAS
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804transcription factors, BMAL1 and CLOCK, that het-
erodimerize to stimulate the expression of other core
circadian genes, such as Period (Per1, 2, and 3), Cryp-
tochrome (Cry1 and 2), and Rev-Erbα. In the negative-
feedback loop, PER and CRY proteins form a het-
eromultimeric complex with another core circadian
regulator, casein kinase I, translocate into the nucleus,
and suppress Per, Cry, and Rev-Erbα transcription by
directly inhibiting the activity of BMAL1/CLOCK hetero-
dimers. The positive and negative loops are connected
by REV-ERBα, which inhibits Bmal1 transcription through
a retinoic-acid-related-orphan-receptor response ele-
ment in the Bmal1 promoter. Importantly for our pur-
pose, mutations in the genes mentioned above (hereaf-
ter collectively referred to as clock genes) affect
circadian behavioral rhythmicity in mice without result-
ing, in most cases, in sterility or obesity (Emery and
Reppert, 2004).
In search of regulators of leptin functions in bone, we
analyzed mice lacking clock components such as Per1
and 2 or Cry1 and 2 (Vitaterna et al., 1999; Zheng et al.,
2001). Although these mutant mice developed a high-
bone-mass phenotype due to an increase in bone for-
mation, there was no evidence that clock genes act up-
stream of leptin to inhibit bone formation. Instead, and
through their expression in osteoblasts, clock genes
mediate the leptin-dependent sympathetic inhibition of
bone formation by suppressing the expression of G1
cyclins and osteoblast proliferation. Removal of molec-
ular-clock function uncovered that leptin and sympa-
thetic signaling exert a countervailing and stimulatory
effect on osteoblast proliferation through the AP-1 fam-
ily of transcription factors. Thus, regulation of bone for-
mation by leptin comprises two antagonistic pathways
whose combined actions determine the rate of osteo-
blast proliferation.
Results
High Bone Mass in Mice Lacking Per or Cry Genes
To determine whether clock genes regulate bone mass,
we studied Per1- and 2- and Cry1- and 2-deficient mice
(Vitaterna et al., 1999; Zheng et al., 2001). Although these
mutant mice showed disrupted circadian behavioral
rhythms, they have, unlike Clock-deficient mice (Turek
et al., 2005), normal body weight, fat-pad weight, food
intake, fertility, and endocrine parameters (Figure 1A
and Figure S1 in the Supplemental Data available with
this article online). Thus, they could be used to deter-
mine whether clock genes participate in the regulation
of bone formation by leptin.
Mice lacking either Per gene (Per1−/− or Per2−/−) or
only the Per2 PAS domain (Per2m/m) had a normal bone
mass as determined by histology and microcomputed
tomography (Figure 1B and data not shown). In con-
trast, starting at 6 weeks of age, Per1−/−;Per2m/m mice
showed a significant increase in bone mass (HBM) that
affected both vertebrae and long bones, a phenotype
that worsened over time (Figures 1B–1D). A HBM of
similar severity was also observed in double mutant
mice lacking the entire Per2 gene (Per1−/−;Per2−/−),
indicating that HBM in these mice was a loss-of-func-
tion phenotype (Figures 1B and 1C). Mice lacking Cry1
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mnd 2 (Cry1−/−;Cry2−/−), two other components of the
olecular clock, exhibited the same HBM as seen in
er1−/−;Per2m/m mice, suggesting that dysfunction of
he molecular clock leads to HBM (Figure 1E).
To identify which arm of bone remodeling was affected
y the loss of clock function, we performed biochemical
nd histomorphometric analyses. Urinary elimination of
eoxypyridinoline crosslinks, a by-product of collagen
egradation, was similar in wild-type (wt) and Per1−/−;
er2m/m mice, indicating that bone resorption was not
vertly affected in these mice (Figure S2A). In contrast,
here was a significant increase in the number of osteo-
lasts and, consequently, in bone-formation parame-
ers (mineral apposition rate and bone-formation rate)
n Per1−/−;Per2m/m, Per1−/−;Per2−/−, and Cry1−/−;Cry2−/−
ice (Figure 1F). The same osteoblast abnormalities
ere also observed in Bmal1−/− mice that did not show
BM (Figure 1F). The absence of HBM in Bmal1−/− mice
ay be explained, at least in part, by their hypogo-
adism, a condition enhancing bone resorption (Figure
1B), although other mechanisms may contribute. That
imilar cellular abnormalities were observed in bones
f multiple clock-gene-deficient mouse models sup-
orts the notion that bone formation is negatively regu-
ated by the molecular clock.
er Genes Mediate Leptin’s Inhibition
f Bone Formation
he resemblance between the bone phenotypes of
er1−/−;Per2m/m, Adrβ2−/−, and ob/ob mice—i.e., in-
reased osteoblast numbers, increased bone-forma-
ion parameters, and HBM—suggested that clock genes
ould either regulate or mediate the leptin-dependent
ympathetic regulation of bone formation. To distin-
uish between these two possibilities, and given the
imilarities between the bone phenotypes of various
lock-gene-deficient mice, we performed subsequent
xperiments in Per1−/−;Per2m/m mice.
Total or bound serum levels of leptin measured every
hr over a 24 hr period were elevated at most time
oints in Per1−/−;Per2m/m mice, although serum levels
f free leptin, the biologically active form of leptin,
ere indistinguishable between wt and Per1−/−;Per2m/m
ice (Figures 2A and 2B). Urinary elimination of cate-
holamines was normal over a 24 hr period in Per1−/−;
er2m/m mice, except for norepinephrine excretion that
as significantly elevated at ZT22 (Figures 2C and 2D).
he activation of the SNS, assessed by expression of
ncoupling protein-1 (Ucp1), a direct target of sympa-
hetic tone (Scarpace and Matheny, 1998), was also in-
reased at ZT22 in Per1−/−;Per2m/m mice (Figure 2E). In
ddition, the increase in urinary elimination of norepi-
ephrine induced by leptin intracerebroventricular (i.c.v.)
nfusion was of similar amplitude in Per1−/−;Per2m/m
nd wt mice (Figure 2F). Taken together, these data
uled out that the HBM of Per1−/−;Per2m/m mice was
ue to a mere decrease in either serum leptin or sympa-
hetic tone (Takeda et al., 2002; Elefteriou et al., 2004).
Instead, the existence of HBM in Per1−/−;Per2m/m
ice in the face of normal free leptin levels and slightly
ncreased sympathetic tone suggested that the clock
enes mediate the sympathetic regulation of bone for-
ation. If this were the case, one would expect that leptin
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805Figure 1. Clock Genes Inhibit Bone Formation
(A) Hormone and mineral ion measurements in 2-month-old wt and Per1−/−;Per2m/m mice.
(B and C) High bone mass (HBM) in vertebrae and distal femora of 6-month-old Per1−/−;Per2m/m and Per1−/−;Per2−/− mice.
(D) Worsening over time of the HBM. Error bars indicate standard error of the mean (±SEM).
(E) HBM in vertebrae of 6-month-old Cry1−/−;Cry2−/− mice.
(F) Elevated bone-formation parameters (BFR, bone-formation rate; MAR, mineral apposition rate) and osteoblast number (Ob.N) in wt and
clock-gene mutant mice at 6 months of age. Bmal1−/− and control mice were studied at 2 months of age before mobility becomes hampered
in Bmal1−/− mice. Asterisks indicate statistically significant differences.i.c.v. infusion in these mice would not decrease bone
mass as it did in wt mice (Ducy et al., 2000). Indeed,
while bone-formation parameters and bone mass de-
creased in wt mice following long-term leptin i.c.v. infu-sion, this treatment consistently increased bone-forma-
tion parameters in Per1−/−;Per2m/m mice (Figure 2G).
Three lines of experimental evidence ruled out that the
failure of leptin i.c.v. infusion to decrease bone mass in
Cell
806Figure 2. Per Genes Mediate Leptin’s Regulation of Bone Formation
(A) Serum level of leptin is elevated in Per1−/−;Per2m/m mice during a 24 hr period (n = 15/time point) (±SEM).
(B) Free serum leptin (arrow) is normal in Per1−/−;Per2m/m mice as assessed by HPLC.
(C and D) Urinary catecholamines are normal or elevated in Per1−/−;Per2m/m mice (±SEM).
(E) Sympathetic tone is normal or elevated in Per1−/−;Per2m/m mice as assessed by Ucp1 expression in brown fat.
(F) The induction of sympathetic tone by leptin is normal in Per1−/−;Per2m/m mice, as indicated by a rise in urinary norepinephrine after leptin
i.c.v. infusion (±SEM).
(G) Paradoxical effects of leptin i.c.v. infusion on bone mass and osteoblast number in Per1−/−;Per2m/m mice. Asterisks indicate statistically
significant differences.
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807Figure 3. Clock Genes Respond to Sympathetic Signaling in Osteoblasts
(A) Clock genes are expressed and cycling in wt but not Per1−/−;Per2m/m bones over a 24 hr period (Northern blots, n = 3). The mutant Per2
mRNA is seen as a faster-migrating band due to an 87 amino acid in-frame deletion. Each RNA band was quantified using a PhosphorImager.
After normalizing to 18S RNA, expression levels for each gene at ZT2 were arbitrarily set as 1. Error bars indicate standard deviation (±SD).
(B) Mean Cre-mediated excision frequency of 81%, assessed by using the 5# loxP probe on HindIII-digested genomic DNA from osteoblast
colony-forming units isolated from wt (lane 1), Per1−/−;Per2lox(ex10–12)/lox(ex10–12) (lane 2), and α1(I)-cre;Per1−/−;Per2lox(ex10–12)/lox(ex10–12) (lane 3)
mice and quantifying the degree of loss of the 7.9 kb band.
(C) HBM with increased number of osteoblasts and bone-formation parameters (BV/TV, %; Ob.N, #/mm2; BFR/TV, %/year; MAR, m3/m2/
year) in α1(I)-cre;Per1−/−;Per2m/lox(ex10–12) mice.
(D) Clock-gene expression is induced by isoproterenol (10 M) in wt but not Per1−/−;Per2m/m osteoblasts.
(E) EMSA: CREB antibody (lane 2), not preimmune serum (lane 1) or ATF4 antibody (lane 3), prevented formation of a protein-DNA complex
(filled arrow) on the Per1 CRE site. A protein-DNA complex formed when nuclear extracts from wt (lane 4) or Atf4−/− (lane 5) osteoblasts were
incubated with a wt Per1 CRE but not a mutant Per1 CRE (lanes 6 and 7). Similar results were obtained using the Per2 CRE site (lanes 8–14).
(F) Induction of Rankl expression by isoproterenol (10 M) is normal in Per1−/−;Per2m/m osteoblasts, as measured by real-time PCR.
(G) Histology of 6-month-old Per1−/−;Per2m/m mice sham operated (Sham) or ovariectomized (OVX) at 2 months of age and Dpd (nmol/mmol
creatinine) elevation demonstrated a normal osteoclastic response to gonadectomy in the absence of Per genes. Asterisks indicate statistic-
ally significant differences.Per1−/−;Per2m/m mice was due to leptin signaling de-
fects. First, this infusion decreased fat-pad weight equ-
ally well in wt and Per1−/−;Per2m/m mice (Figure 2G);
second, leptin receptor (ObRb) expression was normalin Per1−/−;Per2m/m hypothalamus; and third, Per genes
and ObRb were not coexpressed in hypothalamic neu-
rons (data not shown). Thus, the most plausible expla-
nation for the failure of leptin to lower bone mass in
Cell
808Figure 4. Control of Osteoblast Proliferation by Clock Genes
(A) Growth curves of wt and Per1−/−;Per2m/m osteoblasts over 5 days (±SD).
(B) The ratios of G1, S, and G2 phase cells for wt, Per1−/−;Per2m/m, and Adrβ2−/− osteoblasts at 0 and 16 hr after releasing from serum
starvation. Note the increase in G2 population of Per1−/−;Per2m/m and Adrβ2−/− osteoblasts 16 hr after release from G1 arrest, due to synchro-
nized cells progressing into G2/M phase, but not G2/M arrest.
(C) The proportion of S phase cells in wt and Per1−/−;Per2m/m osteoblasts during a 26 hr period was determined by BrdU pulse chasing and
flow cytometry. The time interval between the two S phase peaks was shorter in Per1−/−;Per2m/m osteoblasts than in wt osteoblasts.
(D) Increased osteoblast proliferation in Per1−/−;Per2m/m mice. Mitotic index of calvarial osteoblasts from 6-week-old wt (clear bars) and
Per1−/−;Per2m/m mice (filled bars) (±SEM).
(E) The expression of G1 cyclins in wt, Per1−/−;Per2m/m, and Adrβ2−/− osteoblasts. RNase-protection assay (RPA) shows upregulation of G1
cyclins in mutant osteoblasts. Three independent RPAs are summarized at right (±SD).
(F) Elevated cyclin D1 expression in Per1−/−;Per2m/m bones. PhosphorImager quantification of three independent Northern blots for cyclin D1
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809phoretic mobility shift assays (EMSA). A protein-DNA
expression in wt and Per1−/−;Per2m/m bones during a 24 hr period (±SD).
(G) DNA-cotransfection assays. BMAL1/CLOCK heterodimers inhibit c-myc promoter but not cyclin D1 promoter (±SD).
(H) EMSA: a protein-DNA complex (filled arrowhead) formed when wt but not Bmal1−/− nuclear extracts were incubated with the c-myc −510
E box (left panel), in contrast to normal Sp1 site binding by both extracts (hollow arrowhead).
(I) Elevated c-myc expression in Per1−/−;Per2m/m bones. PhosphorImager quantification of three independent Northern blots for c-myc expres-
sion in wt and Per1−/−;Per2m/m bones during a 24 hr period (±SD).
(J) RPAs showing that isoproterenol (10 M) inhibits G1 cyclins expression in wt (left panel) but not Per1−/−;Per2m/m osteoblasts (right panel).
Asterisks indicate statistically significant differences.
Per2 mice (Figure 4D). At the molecular level, thePer1−/−;Per2m/m mice was that clock genes mediate, in
osteoblasts, the leptin-dependent sympathetic inhibi-
tion of bone formation.
Per Gene Expression, Function, and Regulation
by Sympathetic Tone in Osteoblasts
Consistent with the aforementioned hypothesis, Per1,
Per2, Cry1, Bmal1, and Clock all showed robust, rhyth-
mic expression over a 24 hr period in wt bones, and
their expression was decreased and arrhythmic in
Per1−/−;Per2m/m bones, indicating that bone has a pe-
ripheral clock (Figure 3A). The expression of all clock
genes was also detected in osteoblasts (Figure S4A).
In contrast, the expression of Npas2, whose deletion
does not affect bone mass (M.S.P. and G.K., unpub-
lished data), was not detected in bone or osteoblasts,
although it was detected easily in liver (data not shown).
To determine whether Per genes regulate bone mass
by acting in osteoblasts, we engineered an osteoblast-
specific inactivation of Per2 on a Per1−/− background
since Per1−/− mice did not show a bone phenotype
(Figure S3). To that end, we crossed Per1−/− mice carry-
ing a floxed allele of Per2 with a1(I) collagen-cre mice
that express cre recombinase only in differentiating
osteoblasts (Dacquin et al., 2002). Recombination at
the Per2 locus was effective in osteoblasts and ab-
sent in other cell types (Figure 3B and data not
shown). As was the case for Per1−/−;Per2m/m mice, we
observed HBM, increased osteoblast numbers, and
increased bone-formation parameters in all α1(I)-cre;
Per1−/−;Per2lox(ex10–12)/m mice examined (Figure 3C). To
ascertain that clock-gene expression in osteoblasts is
regulated by sympathetic signaling, we treated wt and
Per1−/−;Per2m/m osteoblasts with isoproterenol, a sym-
pathomimetic. As shown in Figure 3D and Figure S4B,
Bmal1, Per1, and Per2 expression was upregulated by
isoproterenol in wt but not Per1−/−;Per2m/m osteoblasts.
Taken together, these observations establish that clock
genes respond to sympathetic signaling in osteoblasts
to inhibit bone formation.
Transcriptional Mediation of the Sympathetic
Regulation of Per Expression
Adrβ2, the only adrenergic receptor expressed in os-
teoblasts, is a G-coupled protein receptor that most
often uses the transcription factor CREB to regulate
gene expression (Benovic et al., 1988). However, sym-
pathetic signaling in osteoblasts regulates osteoclast
differentiation by using ATF4, an osteoblast-specific
member of the CREB family, as a transcriptional media-
tor (Yang et al., 2004; Elefteriou et al., 2005).
To test whether ATF4 also mediated the sympathetic
regulation of bone formation, we first performed electro-complex formed equally well upon incubation of the
Per1 or Per2 cyclic AMP-response element (CRE) with
wt or Atf4−/− osteoblast nuclear extracts. This complex
could be supershifted by an anti-CREB antibody but
not by an anti-ATF4 antibody (Figure 3E). Furthermore,
isoproterenol induced expression of Rankl, a target
gene of ATF4, to the same extent in wt and Per1−/−;
Per2m/m osteoblasts (Figure 3F) and enhanced Per1
and 2 expression equally well in wt and Atf4−/− osteo-
blasts (Figure S4C). Thus, sympathetic signaling in os-
teoblasts uses different transcriptional mediators to
regulate bone formation, a CREB-mediated process,
and bone resorption, an ATF4-mediated process. That
the integrity of the sympathetic ATF4 signaling pathway
regulating osteoclast differentiation was preserved in
mutant osteoblasts explained why gonadectomy of
Per1−/−;Per2m/m mice resulted in increased osteoclast
function and bone loss (Figure 3G).
Control of Osteoblast Proliferation
by the Molecular Clock
The most striking feature observed in Adrβ2−/−, Per1−/−;
Per2m/m, Per1−/−;Per2−/−, Cry1−/−;Cry2−/−, and Bmal1−/−
mice was a large increase in osteoblast number. Fur-
thermore, while leptin i.c.v. infusion decreased osteo-
blast number in wt mice, it increased it in Per1−/−;
Per2m/m mice. These observations suggested that the
molecular clock inhibits bone formation by preventing
osteoblast proliferation. Consistent with this hypothe-
sis, Per1−/−;Per2m/m bone marrow contained signifi-
cantly greater numbers of stromal and osteoblast pro-
genitor cells than wt controls (Figure S4D), and, when
plated at the same density, Per1−/−;Per2m/m osteoblasts
grew faster than wt osteoblasts, resulting in a larger
cell population at the end of a 5-day culture period (Fig-
ure 4A).
To study cell-cycle progression in wt and Per1−/−;
Per2m/m osteoblasts, cells were synchronized in G1
phase by serum starvation, then refed with fresh me-
dium to initiate cell proliferation. Sixteen hours after re-
feeding, synchronized Per1−/−;Per2m/m osteoblasts had
a 2-fold increase in G2 population as determined by
flow cytometry, whereas wt osteoblasts showed an in-
crease in S but not G2 population (Figure 4B). Next, wt
and Per1−/−;Per2m/m osteoblasts were synchronized in
S phase, returned to normal growth conditions, and
pulse-labeled with BrdU at various times during a 26 hr
period, and the proportion of S phase cells was deter-
mined by flow cytometry. The two S phase peaks were
separated by 24.0 ± 0.2 hr in wt osteoblasts but only
by 21.0 ± 1.0 hr in Per1−/−;Per2m/m osteoblasts (p <
0.05) (Figure 4C). In vivo BrdU labeling confirmed that
the osteoblast mitotic index was elevated in Per1−/−;
m/m
Cell
810expression of G1 cyclins, such as cyclin D1 and E, was
significantly elevated in Per1−/−;Per2m/m osteoblasts
(Figure 4E). Taken together, these different assays dem-
onstrated that Per gene deficiency in osteoblasts re-
sults in elevated G1 cyclin expression that leads to
shortening of the cell cycle and increased cell prolifer-
ation.
Given the central role of cyclin D1 in controlling G1/S
phase transition (Fu et al., 2004), we focused our atten-
tion on this gene. When assessed over 24 hr, cyclin D1
expression was arrhythmic and significantly elevated
at most times in Per1−/−;Per2m/m bones (Figure 4F),
and cyclin D1 protein was more abundant in Per1−/−;
Per2m/m than in wt osteoblasts (Figure S4E). To deter-
mine whether cyclin D1 was a direct target of the mo-
lecular clock, we performed DNA-cotransfection and
DNA binding assays. In DNA-cotransfection experiments,
BMAL1 and CLOCK did not affect cyclin D1 promoter
activity. In EMSA, no binding of osteoblast nuclear ex-
tracts was observed to the cyclin D1 promoter E box
(Figure 4G and data not shown). In contrast, BMAL1/
CLOCK inhibited the promoter activity of c-myc, a criti-
cal regulator of cyclin D1 (Figure 4G), and wt but not
Bmal1−/− osteoblast nuclear extracts could bind to the
proximal E box present in c-myc P1 promoter (Figures
4G and 4H). Consistent with these observations, c-myc
expression was elevated in Per1−/−;Per2m/m bones at
most time points studied and in Per1−/−;Per2m/m osteo-
blasts (Figure 4I and Figure S4F). Thus, one mechanism
whereby clock genes inhibit osteoblast proliferation
is the downregulation of c-myc expression, although
other mechanisms may exist.
A Sympathetic-Signaling Clock-Gene Pathway
Regulates Osteoblast Proliferation
If clock genes mediate the sympathetic inhibition of bone
formation, then the cellular and molecular abnormalities
observed in Per1−/−;Per2m/m osteoblasts should be pres-
ent in Adrβ2−/− osteoblasts. Accordingly, Adrβ2−/− os-
teoblasts showed increases in cell-cycle progression
and cyclin D1 expression similar to Per1−/−;Per2m/m os-
teoblasts (Figures 4B and 4E), and isoproterenol treat-
ment decreased cyclin D1 and E expression in wt but
not Per1−/−;Per2m/m osteoblasts (Figure 4J). Thus, the
sympathetic regulation of clock genes and G1 cyclins in
osteoblasts, the similarity in cell-cycle profile between
Adrβ2−/− and Per1−/−;Per2m/m osteoblasts, and the fail-
ure of leptin i.c.v. infusion to inhibit bone formation in
Adrβ2−/− and Per1−/−;Per2m/m mice all supported the
contention that clock genes act downstream of sympa-
thetic signaling in osteoblasts to inhibit their prolifera-
tion and thereby inhibit bone formation.
Sympathetic Signaling Also Favors Osteoblast
Proliferation via AP-1
Many cellular and molecular features were identical be-
tween Adrβ2−/− and Per1−/−;Per2m/m bones, yet there
was one major difference: leptin i.c.v. infusion paradoxi-
cally increased osteoblast number in Per1−/−;Per2m/m
but had no effect in Adrβ2−/− mice. Such a glaring dis-
crepancy between two models that should phenocopy
each other could be best explained if sympathetic sig-
naling exerts two regulatory actions on osteoblast pro-
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ciferation, one negative through the clock genes and an-
ther positive through yet-to-be-identified genes.
In an effort to identify these genes, we studied the
xpression of transcription factors that affect osteo-
last differentiation and/or proliferation. As shown in
igure 5A, among all the genes tested, c-fos, a gene
hat can induce osteoblast transformation (Grigoriadis
t al., 1995), was most markedly overexpressed in
er1−/−;Per2m/m osteoblasts. Extending the significance
f this finding, expression of most AP-1 genes was in-
reased in Per1−/−;Per2m/m and Adrβ2−/− osteoblasts
Figure 5B). That isoproterenol induced the expression
f several AP-1 genes in wt osteoblasts further estab-
ished that the AP-1 genes are regulated by sympa-
hetic signaling (Figure 5C).
Since c-fos−/− bones showed a decrease in periosteal
steoblast number compared to wt bones (data not
hown) and c-fos was the gene most robustly induced
y isoproterenol, we focused on this AP-1 family mem-
er. When plated at the same density, c-fos−/− osteo-
lasts grew more slowly than wt osteoblasts (Figure
D), indicating that c-Fos controls osteoblast prolifera-
ion. In addition, expression of clock-controlled cell-
ycle genes, such as c-myc and cyclin D1, was de-
reased in c-fos−/− osteoblasts (Figure 5E). While no
anonical AP-1 binding site could be found in the cyclin
1 gene, there was an AP-1 binding site in both human
nd mouse c-myc promoters, and, in EMSA, a protein-
NA complex formed upon incubation of the mouse
-myc AP-1 site with wt but not with c-fos−/− osteoblast
uclear extracts, indicating that c-Fos is part of the
P-1 complex binding to the c-myc promoter (Figure
F). In DNA-cotransfection experiments, AP-1 proteins
ctivated a reporter construct containing four copies of
he wt but not mutant c-myc AP-1 site (Figure 5G).
aken together, these data indicate that sympathetic
ignaling also exerts a positive influence on osteoblast
roliferation via AP-1 proteins. This regulation occurs,
t least in part, by favoring expression of the same cell-
ycle regulators that are downregulated by the clock
enes.
nhibition of AP-1 by the Molecular Clock
f sympathetic signaling in osteoblasts triggers two
athways having opposite effects on cell proliferation,
s there a functional hierarchy and/or crosstalk between
hem? While it is unlikely that c-Fos regulates clock-
ene expression in osteoblasts since c-fos inactivation
id not affect Per2 induction by isoproterenol (Figure
A), several lines of evidence identified the clock genes
s primary regulators of osteoblast proliferation and
P-1 gene expression. First and foremost, osteoblast
umber decreases in wt mice following leptin i.c.v. infu-
ion (Figure 2G). Second, AP-1 genes were overex-
ressed in Per1−/−;Per2m/m osteoblasts (Figure 5B).
hird, isoproterenol induced AP-1 gene expression to a
igher level in Per1−/−;Per2m/m than in wt osteoblasts
Figure 6B). Lastly, in EMSA, wt but not Bmal1−/− osteo-
last nuclear extracts bound to the E box at −454 in
he mouse c-fos promoter (Figure 6C). The presence of
rosstalk between these two pathways suggests that
he increased c-fos expression in Adrβ2−/− osteoblasts
Figure 5B) might be the result of downregulation of the
lock genes in these cells.
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811Figure 5. AP-1 Genes Are Targets of Sympathetic Signaling in Osteoblasts
(A) Expression of transcription factors affecting osteoblast differentiation and proliferation.
(B) AP-1 genes are overexpressed in Per1−/−;Per2m/m and Adrβ2−/− osteoblasts (RPA). Three independent RPAs are summarized at right (±SD).
(C) Induction of AP-1 gene expression in wt osteoblasts by isoproterenol (10 M).
(D) Growth curves for wt and c-fos−/− osteoblasts over 5 days (±SD).
(E) Decreased expression of c-myc and cyclin D1 in c-fos−/− osteoblasts.
(F) EMSA: a protein-DNA complex (filled arrowhead) formed when wt but not c-fos−/− osteoblast nuclear extracts were incubated with the
c-myc AP-1 site, in contrast to normal Sp1 site binding by both extracts (hollow arrowhead).
(G) AP-1 transcription factors enhance the activity of a luciferase reporter construct containing four copies of a wt (clear bars) but not mutant
(filled bars) c-myc AP-1 site (±SD).
(H) Normal induction of c-fos expression in Atf4−/− osteoblasts after isoproterenol treatment (10 M). Asterisks indicate statistically signifi-
cant differences.Leptin Regulates the Expression of AP-1
and Clock Genes In Vivo
The last question we asked was whether the sympa-
thetic regulation of osteoblast proliferation via the clock
and AP-1 genes occurs under the control of leptin sig-
naling. To that end, we used ob/ob mice, a mutantmouse strain that lacks leptin and responds to leptin
i.c.v. infusion with dramatic phenotypic, cellular, and
molecular consequences (Zhang et al., 1994). We tran-
siently infused leptin in the third ventricle of these mice
and, after confirming the expected increase in urine
norepinephrine excretion (Figure S4G), studied gene
Cell
812Figure 6. Crosstalk between Clock and AP-1 Genes
(A) Loss of c-fos function does not affect the induction of Per2 by isoproterenol (10 M) in osteoblasts.
(B) Most AP-1 family members are overinduced by isoproterenol (10 M) in Per1−/−;Per2m/m osteoblasts (RPA). Three independent RPAs are
summarized at right (±SD).
(C) EMSA: a protein-DNA complex (filled arrowhead) formed when wt but not Bmal1−/− nuclear extracts were incubated with the c-fos −454
E box, in contrast to normal Sp1 site binding by both extracts (hollow arrowhead).
(D) Induction of c-fos and Per2 in bone following a single i.c.v. injection of leptin into ob/ob mice. Asterisks indicate statistically significant dif-
ferences.expression in bone at various time points. As shown in
Figure 6D, both Per2 and c-fos expression increased
significantly following this acute injection of leptin, and
the same was true for Clock and additional AP-1 genes
(data not shown). These results established that ex-
pression of these genes is controlled, in part, by leptin.
Discussion
This study demonstrates that clock genes in osteoblasts
mediate the leptin-dependent sympathetic inhibition of
bone formation. It also uncovers that leptin-dependent
sympathetic signaling in osteoblasts promotes cell pro-
l
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piferation by activating AP-1 gene expression (Figure 7)
function of leptin not uncovered by the analysis of
b/ob mice. The regulation of bone formation by leptin
hrough two antagonistic pathways is reminiscent of
he dual mechanism that leptin uses to regulate bone
esorption (Elefteriou et al., 2005).
Candidate Gene Approach to Study Leptin’s
ntiosteogenic Function
hroughout the study of leptin’s regulation of bone
ass, we used a combination of two approaches: clin-
cal observations for discovering a novel physiological
athway and reliance on candidate genes (Ducy et al.,
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813Figure 7. Current Model of the Leptin-Dependent Sympathetic Reg-
ulation of Bone Formation
Through CREB, sympathetic signaling activates the peripheral
clock and AP-1 genes in osteoblasts. The clock genes inhibit os-
teoblast proliferation by inhibiting c-myc, which leads to cyclin D1
downregulation. Counteracting these effects, AP-1 genes promote
osteoblast proliferation by upregulating c-myc and thereby cyclin
D1. The clock genes exert a dominant influence in part because
they also inhibit AP-1 gene expression.2000; Takeda et al., 2002). It is this latter approach that
led us to test whether bone remodeling, like other
homeostatic functions, is regulated by the molecular
clock and resulted in the identification of the two mo-
lecular pathways summarized in Figure 7. Nevertheless,
we are aware of the limitations of this strategy in study-
ing a process as complex as the control of osteoblast
proliferation. Indeed, this approach cannot be as com-
prehensive as a forward genetic approach; therefore,
we cannot exclude that other mediators of clock-gene
regulation of bone formation exist.
Leptin-Dependent Sympathetic Regulation
of Clock-Gene Expression Restrains
Osteoblast Proliferation
It has been proposed that the suprachiasmatic nucleus
is required for the diurnal change in plasma leptin levels
(Kalsbeek et al., 2001), a notion supported by the increase
in serum leptin levels observed in Per1−/−;Per2m/m
mice. However, this increase in serum leptin levels does
not result, as it should, in lower bone mass (Elefteriou
et al., 2004). We show here that this is because clock
genes are required in osteoblasts for the leptin-depen-
dent sympathetic regulation of bone formation to take
place. The evidence supporting this hypothesis includes:
leptin i.c.v. infusion paradoxically increases bone mass
in Per1−/−;Per2m/m mice; clock-gene expression in os-
teoblasts is regulated by sympathetic signaling; and
mice with an osteoblast-specific deletion of Per2
showed increased bone formation, resulting in high
bone mass on a Per1−/− background. Moreover, bone-
marrow transplantation of Per1−/−;Per2m/m osteoblast
precursors into wt recipients led to an increase in bone-
formation parameters (data not shown). That leptin in-fusion activated Per expression in wt bone established
that this regulation occurs in vivo.
A Molecular Blueprint for the Regulation of Osteoblast
Proliferation by Clock Genes
Cell-based assays established that lack of clock genes
favors osteoblast proliferation by accelerating G1/S
phase transition. The molecular experiments suggested
the following model to explain the increased cell prolif-
eration in Per1−/−;Per2m/m osteoblasts. In the absence
of a functional molecular clock, the expression of G1
cyclins, in particular cyclin D1, is increased. The molec-
ular clock controls cyclin D1 expression through an in-
direct mechanism by inhibiting the expression of c-myc,
a critical regulator of cyclin D1 and a gene highly ex-
pressed in osteoblasts (Resnitzky and Reed, 1995;
Perez-Roger et al., 1999). It has been shown previously
that BMAL1/NPAS2 heterodimers inhibit c-myc pro-
moter activity in vitro and that c-myc expression is in-
creased in Per2m/m mouse liver (Fu et al., 2002). How-
ever, NPAS2 is not expressed in bone, and Npas2−/−
mice have a normal bone mass (data not shown). On
the other hand, CLOCK, another partner for BMAL1, is
expressed in osteoblasts and, when cotransfected with
BMAL1, could inhibit c-myc promoter activity in vitro.
We should emphasize that this model does not
exclude the possibility that the molecular clock con-
trols osteoblast proliferation through additional mecha-
nisms. For instance, it has been shown that the molec-
ular clock affects liver regeneration, presumably by
directly controlling the Wee1-mediated G2/M check-
point (Matsuo et al., 2003). Although, under normal
growth conditions, we did not detect abnormal activa-
tion of G2/M checkpoint in Per1−/−;Per2m/m osteoblasts
or a differential expression of Wee1 protein in wt and
Per1−/−;Per2m/m osteoblasts (data not shown), the pos-
sibility remains that Wee1 may regulate osteoblast pro-
liferation under other physiological conditions.
Leptin-Dependent Sympathetic Signaling Favors
Osteoblast Proliferation via AP-1
The increase in osteoblast number in Per1−/−;Per2m/m
mice following leptin i.c.v. infusion uncovered an unan-
ticipated function of leptin for promoting osteoblast
proliferation. Indeed, under the control of leptin, sym-
pathetic signaling in osteoblasts favors AP-1 gene ex-
pression, which in turn induces expression of c-myc
and cyclin D1. This leptin-dependent sympathetic regu-
lation of AP-1 expression explains why the number of
osteoblasts increases in Per1−/−;Per2m/m mice follow-
ing leptin i.c.v. infusion. These data are also consistent
with a growing body of evidence obtained from both
loss-of-function and gain-of-function studies that de-
monstrate that AP-1 plays a role in osteoblast prolifera-
tion and bone formation. These lines of evidence include
the deficiency of cortical osteoblasts in c-fos−/− mice,
the low bone mass seen in Fra1−/− mice, the osteopenia
seen in JunBD/D mice (Kenner et al., 2004), and the
increase in osteoblast proliferation following Fra1 or
FosB overexpression (Jochum et al., 2000; Sabatakos
et al., 2000).
There is a functional hierarchy between the two sympa-
thetic-dependent antagonistic pathways in osteoblasts,
Cell
814and two experimental arguments strongly suggest that
the clock-mediated pathway plays the dominant role.
First, increasing sympathetic tone by leptin i.c.v. infu-
sion decreases osteoblast number in wt mice, a func-
tion ascribed here to the clock genes. Second, expres-
sion of multiple AP-1 genes is increased in the absence
of Per genes, indicating that clock genes control di-
rectly and/or indirectly AP-1 expression (Figure 7).
Unexpected Specificity of the Mediators of Leptin’s
Regulation of Bone Mass
A feature progressively emerging from the molecular
dissection of leptin’s regulation of bone mass is that its
mediators are not involved in a significant manner in
mediating leptin’s other cardinal functions, such as
control of appetite and reproduction, in unchallenged
animals. This specificity of action is surprising in the
case of clock genes, AP-1 genes, and Adrβ2, which are
not osteoblast-specific genes. The narrow specificity of
action of these mediators and the ability of leptin to
regulate powerfully both aspects of bone remodeling,
along with the fact that it first appeared during evolu-
tion in vertebrates, underscore the importance of lep-
tin’s regulation of bone mass and raise the prospect
that this may have been the ancestral function of this
hormone.
Experimental Procedures
Animal Maintenance
Mice were housed in 12 hr:12 hr light/dark cycles with light on at
ZT0 and off at ZT12. Human leptin (Sigma; 8 ng/hr in PBS) or PBS
was infused i.c.v. as described (Ducy et al., 2000) or transiently (3.5
g in 2 l over 6 min) using an infusion pump. Mice were injected
with 25 mg/kg calcein 6 and 2 days prior to sacrifice, and histomor-
phometric analyses were performed as described (Kato et al.,
2002). Mice were injected i.p. with 15 l/g of 25 mM BrdU at ZT2
and ZT14 and were sacrificed 2 hr later, and BrdU was detected as
previously described (Kato et al., 2002).
Cell Culture
Stromal-cell and osteoblast progenitors were cultured according to
Kato et al. (2002). Primary osteoblasts were isolated as in Ducy et
al. (1999) and cultured in αMEM with 10% FBS (Hyclone). Osteo-
blast growth curves were obtained by manual counting and by
crystal violet staining. For cell-cycle studies, osteoblasts were col-
lected after releasing from serum starvation or hydroxyurea (0.5
mM) block and pulse-chasing with BrdU (10 M, 30 min) at various
times and analyzed by a Becton Dickinson FACScan flow cyto-
meter following standard procedures. Lipofectamine (Invitrogen)
was used for transient transfection assays, with β-gal cotransfec-
tion serving as a control.
RNA and Protein Analyses
RNA was prepared from cells treated with isoproterenol (10 M in
PBS) for 20 min in αMEM/0.2% FBS or from bones using TriZOL.
RPA was performed using the RiboQuant multiprobe RPA systems
for mouse AP-1 and cyclin genes (BD Biosciences). Northern blots
and RPAs were quantified using a Molecular Dynamics Storm 860
PhosphorImager/Fluorima. Real-time PCR was performed using an
ABI Prism 7000 Sequence Detection System (Applied Biosystems)
with probes and reagents supplied by the manufacturer. The level
of expression for all mRNAs was normalized to that of 18S rRNA.
Cyclin D1 was detected by Western blot using a cyclin D1-specific
antibody (Santa Cruz Biotechnology) and an anti-β-actin antibody
(Sigma) as a loading control. Electrophoretic mobility shift assays
(EMSA) were performed following standard procedures.
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Fhemistry and Hormone Measurements
eptin (Crystal Chem), estradiol (DSL), PTH (Immunotopics), insulin
Crystal Chem), calcium, and phosphate were measured using
ommercially available kits. Deoxypyridinoline crosslinks were
easured in two consecutive morning urines (ZT3) per mouse
Metra Biosystems) in 6-month-old mice or 2 weeks after ovariec-
omy (OVX). Norepinephrine and epinephrine were measured in
cidified spot urine samples by either TLC (Amersham) or RIA (Bi-
AT; Alpco) with similar results. Creatinine was used to standardize
etween urine samples.
tatistical Analyses
tatistical significance was assessed by Student’s two-tailed t test.
alues were considered statistically significant at p < 0.05.
upplemental Data
upplemental Data include four figures and can be found with this
rticle online at http://www.cell.com/cgi/content/full/122/5/803/
C1/.
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